Table 3. Median availability of surveyed medicines.
Sector | Product types | Median (IQR) availability ofessential medicines | Median (IQR) availability ofnon-essential medicines | p-value |
All sectors | Originator Brand | 0.0% (0.0%–18.4%) | 0.0% (0.0%–21.1%) | 0.579 |
Generic | 53.3% (15.0%–83.3%) | 19.2% (0.0%–64.8%) | 0.000 | |
Any type | 61.5% (20.6%–86.7%) | 27.3% (3.6%–70.0%) | 0.000 | |
Public sector | Originator Brand | 0.0%(0.0%–0.0%) | 0.0% (0.0%–2.0%) | 0.050 |
Generic | 35.0% (9.1%–73.8%) | 5.0% (0.0%–25.0%) | 0.000 | |
Any type | 40.0% (10.0%–75.8%) | 6.6% (0.0%–30.0%) | 0.000 | |
Private sector | Originator Brand | 20.0% (0.0%–55.0%) | 19.5% (0.0%–50.0%) | 0.916 |
Generic | 66.7% (30.8%–86.7%) | 47.4% (6.7%–81.4%) | 0.000 | |
Any type | 78.1% (48.2%–91.6%) | 57.1% (27.3%–87.5%) | 0.000 | |
Other sectors | Originator Brand | 0.0% (0.0%–6.7%) | 0.0% (0.0%–6.7%) | 0.787 |
Generic | 50.0% (13.2%–82.6%) | 20.0% (22.7%–53.1%) | 0.000 | |
Any type | 53.3% (15.0%–84.1%) | 22.2% (4.4%–56.0%) | 0.000 |
IQR = interquartile range.